176 related articles for article (PubMed ID: 34620075)
1. Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8
Xu J; Guo R; Jia J; He Y; He S
BMC Immunol; 2021 Oct; 22(1):67. PubMed ID: 34620075
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells, macrophages, NK and CD8
Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA
Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-35 Dampens CD8
Yang L; Shao X; Jia S; Zhang Q; Jin Z
Front Immunol; 2019; 10():1032. PubMed ID: 31134088
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
[TBL] [Abstract][Full Text] [Related]
6. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-35 Suppresses CD8
Yang L; Zhang Q; Song J; Wang W; Jin Z
Dig Dis Sci; 2020 Dec; 65(12):3614-3623. PubMed ID: 31974915
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling pathway dampens tumor-infiltrating CD8
Yu W; Wang Y; Guo P
Biomed Pharmacother; 2018 Jan; 97():535-542. PubMed ID: 29096354
[TBL] [Abstract][Full Text] [Related]
9. PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
Sawada M; Goto K; Morimoto-Okazawa A; Haruna M; Yamamoto K; Yamamoto Y; Nakagawa S; Hiramatsu K; Matsuzaki S; Kobayashi E; Kawashima A; Hirata M; Iwahori K; Kimura T; Ueda Y; Kimura T; Wada H
Int Immunol; 2020 May; 32(6):397-405. PubMed ID: 32009163
[TBL] [Abstract][Full Text] [Related]
10. TIGIT and PD-1 may serve as potential prognostic biomarkers for gastric cancer.
Xu D; Zhao E; Zhu C; Zhao W; Wang C; Zhang Z; Zhao G
Immunobiology; 2020 May; 225(3):151915. PubMed ID: 32122675
[TBL] [Abstract][Full Text] [Related]
11. [Influence of Toll-like receptor 7 on CD8(+) T lymphocytes in patients with breast cancer].
Qin S; Dong LP; Bai B; Xue HC
Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1562-1566. PubMed ID: 31154723
[No Abstract] [Full Text] [Related]
12. Notch signaling pathway suppresses CD8
Li S; Wang Z; Li XJ
Int Immunopharmacol; 2018 Oct; 63():129-136. PubMed ID: 30086535
[TBL] [Abstract][Full Text] [Related]
13. Tumor antigen-specific CD8
Lu X; Yang L; Yao D; Wu X; Li J; Liu X; Deng L; Huang C; Wang Y; Li D; Liu J
Cell Immunol; 2017 Mar; 313():43-51. PubMed ID: 28110884
[TBL] [Abstract][Full Text] [Related]
14. Inverse relationship between CD40L expression and cytolytic molecule expression by CD8
Xing J; Li X; E J; Wang C; Wang H
Exp Cell Res; 2020 Apr; 389(1):111892. PubMed ID: 32035135
[TBL] [Abstract][Full Text] [Related]
15. Distribution, phenotype, functional and clinical relevance of CD8
Shen Y; Li XL; Li YX; Shan ZG; Zhao YL; Cheng P; Zhao Z; Zhang JY; Chen W; Zhuang Y; Ma DY; Zou QM; Qiu Y; Peng LS
Cancer Immunol Immunother; 2022 Jul; 71(7):1645-1654. PubMed ID: 34767045
[TBL] [Abstract][Full Text] [Related]
16. Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation.
McCarron M; Reen DJ
J Immunol; 2009 Jan; 182(1):55-62. PubMed ID: 19109135
[TBL] [Abstract][Full Text] [Related]
17. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8
Freen-van Heeren JJ
Scand J Immunol; 2021 May; 93(5):e13019. PubMed ID: 33377182
[TBL] [Abstract][Full Text] [Related]
19. CD8
Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.
Joseph AM; Srivastava R; Zabaleta J; Davila E
Cancer Immunol Res; 2016 Aug; 4(8):708-16. PubMed ID: 27267778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
